Menu
Back to Journals » Clinical Ophthalmology » Volume 2 » Issue 1
Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
Authors Ruiz-Moreno JM, Montero JA
Published 7 March 2008 Volume 2008:2(1) Pages 71—75
José Mª Ruiz-Moreno1,2, Javier A Montero2
1Department of Ophthalmology, Miguel Hernández University School of Medicine, Alicante, Spain; 2Vitreo-Retinal Unit, Alicante Institute of Ophthalmology, Alicante, Spain
Abstract: Choroidal neovascularization (CNV) secondary to age related macular degeneration is among the leading causes of legal blindness in developed countries. Photodynamic therapy (PDT) with verteporfin induces CNV closure causing little damage to healthy tissue, but the need to re-treat may lead to low final visual acuity at an unacceptable cost. The association of intravitreous triamcinolone or antiangiogenic drugs with PDT has been used in order to reduce these limitations of the therapy. The combination of PDT and intravitreous triamcinolone, its complications and outcome at one and two-year follow-up are discussed.
Keywords: age related macular degeneration, choroidal neovascularization, photodynamic therapy, steroid, triamcinolone
© 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.